Robin Hanson – Economist Writing Every Day

I’m back from Manifest, a conference on prediction markets, forecasting, and the future. It was an incredible chance to hear from many of my favorite writers on the internet, along with the CEOs of most major prediction markets; in Steve Hsu’s words, Woodstock for Nerds. Some highlights:

Robin Hanson took over my session on academic research on prediction markets (in a good way; once he was there everyone just wanted to ask him questions). He thinks the biggest current question for the field is to figure out why is the demand for prediction markets so low. What are the different types of demand, and which is most likely to scale? In a different talk, Robin says that we need to either turn the ship of world culture, or get off in lifeboats, before falling fertility in a global monoculture wrecks it.

Play-money prediction markets were surprisingly effective relative to real-money ones in the 2022 midterms. Stephen Grugett, co-founder of Manifold (the play-money prediction market that put on the conference), admitted that success in one election could simply be a coincidence. He himself was surprised by how well they did in the 2022 midterms, and said he lost a bunch of mana on bets assuming that Polymarket was more accurate.

Substack CEO Chris Best: No one wants to pay money for internet writing in the abstract, but everyone wants to pay their favorite writer. For me, that was Scott Alexander. We are trying to copy Twitter a bit. Wants to move into improving scientific publishing. I asked about the prospects of ending the feud with Elon; Best says Substack links aren’t treated much worse than any other links on X anymore.

Razib Khan explained the strings he had to pull for his son to be the first to get a whole genome sequence in utero back in 2014- ask the hospital to do a regular genetic test, ask them for the sample, get a journalist to tweet at them when they say no, get his PI’s lab to run the sample. He thinks crispr companies could be at the nadir of the hype cycle (good time to invest?).

Kalshi cofounder Luana Lopes Lara says they are considering paying interest on long term markets, and offering margin. There is enough money in it now that their top 10 or so traders are full time (earning enough that they don’t need a job). The CFTC has approved everything we send them except for once (elections). We don’t think their current rule banning contest markets will go through, but if it does we would have to take down Oscar and Grammy markets. When we get tired of the CFTC, we joke that we should self certify shallot futures markets (toeing the line of the forbidden onion futures). Planning to expand to Europe via brokerages. Added bounty program to find rules problems. Launching 30-50 markets per week now (seems like a good opportunity, these can’t all be efficient right?).

There was lots else of interest, but to keep things short I’ll just say it was way more fun and informative doing yet another academic conference, where I’ve hit diminishing returns. More highlights from Theo Jaffee here; I also loved economist Scott Sumner’s take on a similar conference at the same venue in Berkeley:

If you spend a fair bit of time surrounded by people in this sector, you begin to think that San Francisco is the only city that matters; everywhere else is just a backwater. There’s a sense that the world we live in today will soon come to an end, replaced by either a better world or human extinction. It’s the Bay Area’s world, we just live in it.

When you look across countries, it appears that the first $1000 per person per year spent on health buys a lot; spending beyond that buys a little, and eventually nothing. The US spends the most in the world on health care, but doesn’t appear to get much for it. A classic story of diminishing returns:

*Source: https://twitter.com/MaxCRoser/status/810077744075866112/photo/1*

This might tempt you to go full Robin Hanson and say the US should spend dramatically less on health care. But when you look at the same measures across US states, it seems like health care spending helps after all:

*Source: My calculations from 2019 IHME Life Expectancy and 2019 KFF Health Spending Per Capita*

Last week though, I showed how health spending across states looks a lot different if we measure it as a share of GDP instead of in dollars per capita. When measured this way, the correlation of health spending and life expectancy turns sharply negative:

*Source: My calculations from 2019 IHME life expectancy, Gross State Product, and NHEA provider spending*

Does this mean states should be drastically cutting health care spending? Not necessarily; as we saw before, states spending more dollars per person on health is associated with longer lives. States having a high share of health spending does seem to be bad, but this is more because it means the rest of their economy is too small, rather than health care being too big. Having a larger GDP per capita doesn’t just mean people are materially better off, it also predicts longer life expectancy:

*Source: My calculations from 2019 IHME life expectancy and 2019 Gross State Product*

As you can see, higher GDP per capita predicts longer lives even more strongly than higher health spending per capita. Here’s what happens when we put them into a horse race in the same regression:

The effect of health spending goes negative and insignificant, while GDP per capita remains positive and strongly significant. The coefficient looks small because it is measured in dollars, but what it means is that a $10,000 increase in GDP per capita in a state is associated with 1.13 years more life expectancy.

My guess is that the correlation of GDP and life expectancy across states is real but mostly not caused by GDP itself; rather, various 3rd factors cause both. I think the lack of effect of health spending across states is real, between diminishing returns to spending and the fact that health is mostly not about health care. Perhaps Robin Hanson is right after all to suggest cutting medicine in half.